Views & Analysis Dynamic consent models can benefit clinical trials Dynamic consent models for patients can develop ongoing partnership between participants and researchers.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
